Company Filing History:
Years Active: 2013-2015
Title: Innovations in Oncology: The Patents of Shijun Lin
Introduction
Shijun Lin, an accomplished inventor based in Shanghai, China, has made significant contributions to the field of medicinal chemistry, particularly in the development of new treatments for cancer. With two approved patents to his name, his work reflects a deep commitment to improving therapeutic options for patients suffering from tumors.
Latest Patents
Lin's recent inventions focus on a class of compounds known as pyridazinones, specifically aimed at targeting liver cancer. His first patent, titled "Substituted Pyridazinones for the Treatment of Tumors," details a novel approach utilizing 6-[3-(trifluoromethyl)phenyl]pyridazin-3(2H)-one as the mother nucleus. This invention outlines both the preparation methods and the potential applications of these compounds in constructing medicaments that could offer new hope for liver cancer treatment.
In his second patent, "Derivatives of 6[3-(trifluoromethyl)phenyl]pyridazin-3(2H)-one Having Antitumor Activity," Lin expands upon his initial findings, reinforcing the therapeutic benefits of his pyridazinone derivatives. The meticulous detail provided in both patents serves as a testament to his innovative approach in the fight against tumors.
Career Highlights
Shijun Lin is presently affiliated with the Chinese Academy of Sciences, where he has dedicated his research to advancing cancer treatment methodologies. His academic foundation and ongoing projects have positioned him as a leading figure in his field, attracting attention from both the medical community and pharmaceutical companies seeking to develop new cancer therapies.
Collaborations
Lin's work is further enriched by collaborations with notable colleagues, including Youhong Hu and Liguang Lou. The synergy between these professionals fosters a creative environment that enhances their research endeavors. Their collective expertise is instrumental in the evolution of Lin's groundbreaking cancer treatments.
Conclusion
With two patents that underscore the potential of pyridazinones in oncology, Shijun Lin is paving the way for novel therapeutic strategies against liver cancer. His dedication to research, collaboration with esteemed colleagues, and work at the Chinese Academy of Sciences highlight the crucial role inventors like him play in the ongoing fight against cancer. As research progresses, Shijun Lin’s contributions in medicinal innovation continue to inspire hope for a healthier future.